Actively Recruiting
Comparison Of iStent to Laser in Exfoliation Glaucoma Helsinki Study Group
Led by Helsinki University Central Hospital · Updated on 2020-11-18
285
Participants Needed
1
Research Sites
674 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the study is to investigate the efficacy of an iStent trabecular microbypass stent compared to selective laser trabeculoplasty in combination with cataract surgery in eyes with exfoliation glaucoma (EXF)
CONDITIONS
Official Title
Comparison Of iStent to Laser in Exfoliation Glaucoma Helsinki Study Group
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed consent of information
- Presence of clinically significant cataract
- Ability to attend all visits during a 12-month period
- Diagnosis of mild to moderate exfoliation glaucoma according to European glaucoma society guidelines
- Stable glaucoma with intraocular pressure (IOP) within individual target IOP or unstable glaucoma with IOP above target with baseline glaucoma medication
- Target intraocular pressure of 16 mmHg or higher
- Ability to understand Finnish, Swedish, or English
You will not qualify if you...
- Target intraocular pressure less than 16 mmHg in advanced glaucoma
- Baseline intraocular pressure prior to enrollment of 30 mmHg or higher and use of 3 or more glaucoma medications
- Closed angle or congenital angle anomaly
- Clinically significant corneal dystrophy or other corneal conditions that hinder treatment
- Inability to use topical medical therapy
- Central corneal thickness less than 480 micrometers or more than 620 micrometers
- Active uveitis, cystic macular edema, exudative age-related macular degeneration, proliferative diabetic retinopathy, significant macular edema, intraocular neoplasm, intraocular injections, intraocular lens luxation, or phacodonesis
- Previous intraocular surgery, refractive surgery, or cycloablation
- Two or more prior selective laser trabeculoplasty or laser trabeculoplasty treatments
- Inability to participate due to other medical diseases or conditions
- Participation in another clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Helsinki University Hospital
Helsinki, Finland
Actively Recruiting
Research Team
E
Eeva Ojanen, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
5
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here